Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:32:49.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:34:14.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page adds Revision: v3.4.2, and removes a government funding lapse notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:09:17.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A government funding lapse notice now appears on the page, stating that information may not be up to date. The site version was updated to Revision: v3.4.1, replacing v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T10:18:19.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and a new 'Revision: v3.4.0' label; minor metadata updates include capitalization changes for labels and removal of older entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:01:15.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    - Page revision label updated from v3.3.3 to v3.3.4. This appears to be a versioning update and does not alter the study content on the page.
    Difference
    0.1%
    Check dated 2026-01-14T02:28:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.